SEC Form 4 · accession 0001144204-15-003781
INTERLEUKIN GENETICS INC · ILIU
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Scott A. Snyder
Officer — Chief Marketing Officer
Period of report
Jan 22, 2015
Accepted (ET)
Jan 26, 2015 · 4:04 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001037649
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1,F2 | $0.26 | Jan 22, 2015 | A | 660,000 | A | — | Jan 22, 2025 | Common Stock | 660,000 | 660,000 | D |
Explanation of responses
- F1The exercise price of the option is the closing price of the Issuer's common stock on the OTCQB on 1/22/2015, which was the grant date of the option.
- F2The option vests as to 1/48 of the shares on the first day of each month beginning on February 1, 2015.